Belpointe Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Belpointe Asset Management’s Portfolio COLL Stock Details COLL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$994K	Hold	27,467	–	–	0.03%	500
2026 Q1	$908K	Buy	27,467 +10,729	+64%	+$454K	0.03%	493
2025 Q4	$775K	Buy	16,738 +3,048	+22%	+$128K	0.03%	526
2025 Q3	$479K	Hold	13,690	–	–	0.02%	641
2025 Q2	$405K	Buy	13,690 +30	+0.2%	+$856	0.02%	654
2025 Q1	$408K	Buy	+13,660	New	+$417K	0.02%	619
2023 Q2	–	Sell	-1,144	Closed	-$27.4K	–	1111
2023 Q1	$27.4K	Buy	1,144 +228	+25%	+$6.05K	﹤0.01%	2115
2022 Q4	$21.3K	Buy	+916	New	+$18.5K	﹤0.01%	2140

Other funds holding COLL

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Jupiter Topco New York $245B AUM

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Principal Financial Group Des Moines, Iowa $204B AUM 27.99% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

EAM

Eventide Asset Management Boston, Massachusetts $7.48B AUM 104.76% 1-Year Est. Return

Belpointe Asset Management's COLL Position: Q2 2026 in Review

Belpointe Asset Management held its Collegium Pharmaceutical (COLL) position steady in Q2 2026 at 27,467 shares worth $994K. The position accounts for 0.03% of the portfolio, ranked #500.

Belpointe Asset Management first reported a position in COLL in Q4 2022 and has held it in 8 quarters since. 279 funds tracked by Wall St. Rank hold COLL as of Q2 2026.

Belpointe Asset Management held 27,467 shares of Collegium Pharmaceutical worth $994K as of Q2 2026.
Belpointe Asset Management left its Collegium Pharmaceutical share count unchanged in Q2 2026.
Collegium Pharmaceutical made up 0.03% of Belpointe Asset Management's portfolio in Q2 2026, its #500 holding.
Belpointe Asset Management first reported a position in Collegium Pharmaceutical in Q4 2022 and has held it in 8 quarters since.
279 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q2 2026.

Based on Belpointe Asset Management's 13F filing for Q2 2026, filed 31 Jul 2026.